Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke

BACKGROUND: Stroke remains a leading cause of death and disability worldwide despite recent treatment breakthroughs. A primary event in stroke pathogenesis is the development of a potent and deleterious local and peripheral inflammatory response regulated by the pro-inflammatory cytokine interleukin...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmeron, Kathleen E., Maniskas, Michael E., Edwards, Danielle N., Wong, Raymond, Rajkovic, Ivana, Trout, Amanda, Rahman, Abir A., Hamilton, Samantha, Fraser, Justin F., Pinteaux, Emmanuel, Bix, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857151/
https://www.ncbi.nlm.nih.gov/pubmed/31727174
http://dx.doi.org/10.1186/s12974-019-1599-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857151/
https://www.ncbi.nlm.nih.gov/pubmed/31727174
http://dx.doi.org/10.1186/s12974-019-1599-9

Ejemplares similares